ReSTORing good vision

Article

The diffractive AcrySof ReSTOR (Alcon) intraocular lens (IOL) can provide stable, high levels of spectacle independence for both near and distance vision.

The diffractive AcrySof ReSTOR (Alcon) intraocular lens (IOL) can provide stable, high levels of spectacle independence for both near and distance vision, according to Rudy Nuijts and colleagues from the Academic Hospital Maastricht, The Netherlands.

A total of 45 eyes of 23 patients who received the ReSTOR SA60D3 IOL were followed in a prospective trial. Patients were assessed preoperatively and six months and three years postoperatively.

No significant changes in uncorrected distance visual acuity (UCDVA) and best corrected distance visual acuity (BCDVA) were noted between the six month and three year time points.

At six months postoperatively, 78% and 83% of patients no longer required spectacles for near and distance vision respectively. At three years 73% and 74% of patients still did not require spectacles for near and distance vision, respectively. Near vision without glasses at six months and three years was 4.0 and 3.7, respectively and 4.3 and 3.8 for distance vision, respectively. Ninety percent of subjects declared themselves to be satisfied with intermediate vision tasks at both time points. Moderate to severe glare was reported by 9.9% and 4.3% at six months and three years and halos were reported by 8.7% and 4.3%, respectively.

Dr Nuijts and his colleagues concluded that the ReSTOR lens achieves excellent near and distance visual results in the majority of patients.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
© 2025 MJH Life Sciences

All rights reserved.